Q2 2026 saw 4% revenue growth and 3% gross billings growth, but net income fell to $12.9 million due to lower favorable claims adjustments and margin pressure. Capital returns to shareholders exceeded $39 million year-to-date, and guidance projects modest growth for the remainder of 2026.Original d…
Q2 2026 saw 4% revenue growth and 3% gross billings growth, but net income fell to $12.9 million due to lower favorable claims adjustments and margin pressure. Capital returns to shareholders exceeded $39 million year-to-date, and guidance projects modest growth for the remainder of 2026.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
